These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 10780189

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Lipoprotein (a) and coronary heart disease among women: beyond a cholesterol carrier?
    Shai I, Rimm EB, Hankinson SE, Cannuscio C, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.
    Eur Heart J; 2005 Aug; 26(16):1633-9. PubMed ID: 15824077
    [Abstract] [Full Text] [Related]

  • 23. Correlation between lipoprotein(a) and other risk factors for cardiovascular disease and diabetes in Cherokee Indians: the Cherokee Diabetes Study.
    Wang W, Lee ET, Alaupovic P, Blackett P, Blevins KS.
    Ann Epidemiol; 2005 May; 15(5):390-7. PubMed ID: 15840553
    [Abstract] [Full Text] [Related]

  • 24. Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease.
    Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M, Scharnagl H, Koenig W, Brenner H.
    Eur J Cardiovasc Prev Rehabil; 2003 Oct; 10(5):362-70. PubMed ID: 14663298
    [Abstract] [Full Text] [Related]

  • 25. Comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease.
    Cicek H, Bayil S, Zer Y, Celik A, Geyikli I.
    Ann N Y Acad Sci; 2007 Apr; 1100():179-84. PubMed ID: 17460176
    [Abstract] [Full Text] [Related]

  • 26. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M.
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [Abstract] [Full Text] [Related]

  • 27. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A, Darapladib Investigators.
    J Am Coll Cardiol; 2008 Apr 29; 51(17):1632-41. PubMed ID: 18436114
    [Abstract] [Full Text] [Related]

  • 28. Elevated lipoprotein (a) and apolipoprotein B to AI ratio in South Asian patients with ischaemic stroke.
    Sharobeem KM, Patel JV, Ritch AE, Lip GY, Gill PS, Hughes EA.
    Int J Clin Pract; 2007 Nov 29; 61(11):1824-8. PubMed ID: 17935546
    [Abstract] [Full Text] [Related]

  • 29. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB, Weis SE, Willis JM, Vasenius KA, McConathy WJ.
    J Am Osteopath Assoc; 2002 Jul 29; 102(7):377-84. PubMed ID: 12138952
    [Abstract] [Full Text] [Related]

  • 30. Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.
    Ranga GS, Kalra OP, Tandon H, Gambhir JK, Mehrotra G.
    J Stroke Cerebrovasc Dis; 2007 Jul 29; 16(5):220-4. PubMed ID: 17845920
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Lipoprotein in children and adolescents: relationship with family history of coronary artery disease].
    Casanueva V, Cid X, Calvo C, Chiang MT, Ulloa N, Milos C, Rodríguez W, Elgueta F.
    Rev Med Chil; 1996 Jul 29; 124(7):799-804. PubMed ID: 9138367
    [Abstract] [Full Text] [Related]

  • 34. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
    Cubrilo-Turek M, Sertić J, Duraković Z.
    Acta Med Croatica; 2001 Jul 29; 55(4-5):161-7. PubMed ID: 12398019
    [Abstract] [Full Text] [Related]

  • 35. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
    Muhonen LE, Burns TL, Nelson RP, Lauer RM.
    Pediatrics; 1994 Mar 29; 93(3):444-51. PubMed ID: 8115204
    [Abstract] [Full Text] [Related]

  • 36. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A, Kadzielewski J, Janowski K, Roliński J, Krasowska D, Chodorowska G, Paszkowski T, Kapeć E, Jastrzebska I, Tabarkiewicz J, Lotti T.
    Int J Dermatol; 2009 Apr 29; 48(4):379-87. PubMed ID: 19335423
    [Abstract] [Full Text] [Related]

  • 37. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA, Carmina E.
    Int J Clin Pract; 2009 Jan 29; 63(1):56-62. PubMed ID: 19125993
    [Abstract] [Full Text] [Related]

  • 38. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP, Pépin GM, Mahley RW.
    Am Heart J; 2003 Dec 29; 146(6):1052-9. PubMed ID: 14660998
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, Singh AK, Gupta JB, Kaul V.
    Indian Heart J; 2002 Dec 29; 54(1):59-66. PubMed ID: 11999090
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.